万孚生物(300482.SZ)：取得产品注册证

Core Viewpoint - Wanfu Bio (300482.SZ) has received a medical device registration certificate from the National Medical Products Administration for a nucleic acid detection kit for influenza A virus, influenza B virus, and respiratory syncytial virus (RSV), marking a significant advancement in respiratory pathogen detection [1] Group 1: Product Development - The newly approved product is a key breakthrough in the field of respiratory pathogen detection, which is crucial for addressing acute respiratory infections globally [1] - The product utilizes fluorescent PCR technology, aligning with the company's strategic focus on molecular diagnostics as a core driver of precision medicine [1] Group 2: Competitive Positioning - This new kit will complement the existing product line, enhancing the respiratory disease detection matrix and strengthening the company's overall competitiveness in the in vitro diagnostics sector [1]